Graphpad

GraphPad Prism provides researchers worldwide with purpose-built tools to save time, simplify data analysis, and elegantly graph and present your scientific research. Prism has been trusted by more than of the world’s leading scientists, from students to Nobel Prize winners, in institutions and organizations including Stanford, Yale, Harvard, City of Hope, Center for Disease Control and Prevention (CDC), NASA, Merck, Sanofi, and more. Founded by Dr. Harvey Motulsky - a renowned pharmacologist, biostatistician, and author of the best selling Intuitive Biostatistics: A Nonmathematical Guide to Statistical Thinking. In 2022, Graphpad Prism integrated with Dotmatics’ enterprise R&D platform. Dotmatics is a leader in R&D scientific software connecting science, data, and decision-making. Its enterprise R&D platform and scientists’ favorite applications drive efficiency and accelerate innovation. More than 2 million scientists and customers trust Dotmatics to help them create a healthier, cleaner, safer world. Dotmatics is a global team of more than 800 people dedicated to supporting its customers in over 180 countries. The company’s principal office is in Boston, with 14 offices and R&D teams located around the world. Dotmatics is backed by Insight Partners, a leading global venture capital and private equity firm investing in high-growth technology and software scaleup companies. Learn more about Dotmatics, its platform, and applications including GraphPad Prism, Geneious, SnapGene, Protein Metrics, and LabArchives at Visit GraphPad.com and discover how the world’s leading scientists use Prism to save time, make more accurate analysis choices, and elegantly graph and present their scientific research.